Market LIVE
Published markets; coverage varies by country
Product profile · United States

BAXDELA

 ·  Patent Litigation & Settlement History ↓

IngredientDELAFLOXACIN MEGLUMINE
Application typeNDA
Application208611
Product001
Dosage formPOWDER
RouteINTRAVENOUS
StrengthEQ 300MG BASE/VIAL
Approval date2017-06-19
Marketing statusPrescription
Status event—
ApplicantMELINTA
Product source

Current GenericRadar decision

Year2027
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typeREGULATORY_EXCLUSIVITY
Anchor date2027-06-19
Patent anchor2026-10-02
Exclusivity anchor2027-06-19
Protection date2034-06-02
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2027. Anchor type: REGULATORY_EXCLUSIVITY. Patent anchor: 2026-10-02. Exclusivity anchor: 2027-06-19. Anchor date: 2027-06-19. Patent tail: yes. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
82738922026-08-06DS —YNTRUE_DS
English description not available.
———
82738922026-08-06ORANGE_BOOK —YNTRUE_DS
English description not available.
———
82528132026-10-02DP/U U-2028NYU
English description not available.
———
82528132026-10-02ORANGE_BOOK U-2028NYU
English description not available.
———
76357732029-03-13DP —NNDP
English description not available.
———
76357732029-03-13ORANGE_BOOK —NNDP
English description not available.
———
84100772029-03-13DP —NNDP
English description not available.
———
84100772029-03-13ORANGE_BOOK —NNDP
English description not available.
———
92000882029-03-13DP —NNDP
English description not available.
———
92000882029-03-13ORANGE_BOOK —NNDP
English description not available.
———
97508222029-03-13DP —NNDP
English description not available.
———
97508222029-03-13ORANGE_BOOK —NNDP
English description not available.
———
88719382029-09-23DS —NNPROCESS
English description not available.
———
88719382029-09-23ORANGE_BOOK —NNPROCESS
English description not available.
———
RE466172029-12-28DS —NNPROCESS
English description not available.
———
RE466172029-12-28ORANGE_BOOK —NNPROCESS
English description not available.
———
77281432031-06-19DS —NNDP
English description not available.
———
77281432031-06-19ORANGE_BOOK —NNDP
English description not available.
———
121382572032-05-01DP —NNDP
English description not available.
———
121382572032-05-01ORANGE_BOOK —NNDP
English description not available.
———
94935822033-02-27DP —NNPROCESS
English description not available.
———
94935822033-02-27ORANGE_BOOK —NNPROCESS
English description not available.
———
125583492034-03-14U U-3967NNU
English description not available.
———
125583492034-03-14ORANGE_BOOK U-3967NNU
English description not available.
———
120362192034-06-02U U-3967NNU
English description not available.
———
120362192034-06-02ORANGE_BOOK U-3967NNU
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2017-06-192022-06-19English description not available.YY2022-06-19—Source
NCE2017-06-192022-06-19English description not available.YY2022-06-19
GAIN
Full coverage date: 2022-06-19
Source
I-8152019-10-242022-10-24English description not available.NN—
GAIN
Full coverage date: —
Source
GAIN2022-06-192027-06-19English description not available.YY2027-06-19—Source
GAIN2022-06-192027-06-19English description not available.YY2027-06-19
GAIN
Full coverage date: 2027-06-19
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (17)
TypeDateRoleBasisSource
PATENT2026-08-06HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2026-10-02CANONICAL_ANCHOREnglish description not available.Source
PATENT2029-03-13FTO_TAILEnglish description not available.Source
PATENT2029-03-13FTO_TAILEnglish description not available.Source
PATENT2029-03-13FTO_TAILEnglish description not available.Source
PATENT2029-03-13FTO_TAILEnglish description not available.Source
PATENT2029-09-23FTO_TAILEnglish description not available.Source
PATENT2029-12-28FTO_TAILEnglish description not available.Source
PATENT2031-06-19FTO_TAILEnglish description not available.Source
PATENT2032-05-01FTO_TAILEnglish description not available.Source
PATENT2033-02-27FTO_TAILEnglish description not available.Source
PATENT2034-03-14FTO_TAILEnglish description not available.Source
PATENT2034-06-02FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—CANONICAL_ANCHOREnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2027-06-19CANONICAL_DECISIONEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.